AU
UK
CA
NZ
IND
US
Last update at 2026-06-23T20:00:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates CCRN and LBRDA on Behalf of Shareholders
Thu 30 Jan 25, 01:54 PMSHAREHOLDER NOTICE: Halper Sadeh LLC Investigates OMIC, CCRN, OMC on Behalf of Shareholders
Tue 28 Jan 25, 01:23 PMKuehn Law Encourages NARI, QTRX, CCRN, and VTS Investors to Contact Law Firm
Fri 24 Jan 25, 02:12 PM| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -83.51000M | -16.39800M | 102.89M | 256.32M | 133.21M |
| Minority interest | - | - | - | 0.00000M | 0.00000M |
| Net income | -94.85200M | -14.55600M | 72.63M | 188.46M | 132.00M |
| Selling general administrative | 200.68M | 246.31M | 303.45M | 324.21M | 215.29M |
| Selling and marketing expenses | - | 8.50M | 11.50M | - | - |
| Gross profit | 196.78M | 274.25M | 450.41M | 627.69M | 375.00M |
| Reconciled depreciation | 16.79M | 18.20M | 17.04M | 12.58M | 9.85M |
| Ebit | -3.46200M | -0.72500M | 110.99M | 273.11M | 139.30M |
| Ebitda | 13.33M | 16.77M | 129.34M | 304.81M | 160.48M |
| Depreciation and amortization | 16.79M | 17.50M | 18.35M | 31.70M | 21.17M |
| Non operating income net other | - | - | - | -2.39200M | 0.77M |
| Operating income | -3.46200M | -16.86500M | 112.71M | 273.11M | 139.30M |
| Other operating expenses | 1057.76M | 1360.87M | 1907.02M | 2515.71M | 1526.80M |
| Interest expense | 2.22M | 2.19M | 8.09M | 14.39M | 6.87M |
| Tax provision | 11.34M | -1.84200M | 33.89M | 67.86M | 1.21M |
| Interest income | 3.13M | 2.05M | 0.08M | - | - |
| Net interest income | 0.91M | -0.13800M | -11.02300M | -14.39100M | -6.86600M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | 17.07M | 9.48M |
| Other items | - | - | - | - | - |
| Income tax expense | 11.34M | -1.84200M | 30.26M | 67.86M | 1.21M |
| Total revenue | 1054.29M | 1344.00M | 2019.73M | 2806.61M | 1676.65M |
| Total operating expenses | 200.24M | 291.12M | 337.70M | 336.79M | 225.14M |
| Cost of revenue | 857.52M | 1069.75M | 1569.32M | 2178.92M | 1301.65M |
| Total other income expense net | -80.04800M | 0.47M | -9.81900M | -16.78300M | -6.09600M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -94.85200M | -14.55600M | 102.38M | 188.46M | 132.00M |
| Net income applicable to common shares | - | - | - | 188.46M | 132.00M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 448.95M | 589.25M | 679.32M | 947.84M | 732.81M |
| Intangible assets | 27.64M | 42.19M | 54.47M | 44.72M | 48.24M |
| Earning assets | - | - | - | - | - |
| Other current assets | 17.34M | 10.48M | 9.71M | 1.04M | 0.64M |
| Total liab | 126.13M | 170.29M | 205.92M | 490.62M | 435.28M |
| Total stockholder equity | 322.82M | 418.96M | 473.39M | 457.22M | 297.53M |
| Deferred long term liab | - | - | - | 3.44M | 0.99M |
| Other current liab | 30.56M | 87.96M | 76.60M | 82.00M | 8.86M |
| Common stock | 0.00300M | 0.00300M | 0.00400M | 0.00400M | 0.00400M |
| Capital stock | 0.00300M | 0.00300M | 0.00400M | 0.00400M | 0.00400M |
| Retained earnings | 123.21M | 218.06M | 238.36M | 165.73M | -22.73500M |
| Other liab | - | - | - | 65.36M | 48.29M |
| Good will | 63.80M | 135.06M | 135.43M | 163.27M | 119.49M |
| Other assets | - | - | - | 36.79M | 33.48M |
| Cash | 108.74M | 81.63M | 17.09M | 3.60M | 1.04M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 77.76M | 120.40M | 148.59M | 271.64M | 199.77M |
| Current deferred revenue | - | - | - | - | 72.89M |
| Net debt | -106.42000M | -77.76200M | -11.82700M | 154.14M | 194.45M |
| Short term debt | 1.16M | 2.09M | 2.60M | 4.13M | 8.27M |
| Short long term debt | - | - | - | - | 4.18M |
| Short long term debt total | 2.32M | 3.87M | 5.27M | 157.75M | 195.49M |
| Other stockholder equity | 201.17M | 202.34M | 236.42M | 292.88M | 321.55M |
| Property plant equipment | - | - | - | 19.66M | 23.32M |
| Total current assets | 293.59M | 335.00M | 415.15M | 675.67M | 508.27M |
| Long term investments | - | - | - | 23.06M | - |
| Net tangible assets | - | - | - | 412.50M | 129.79M |
| Short term investments | - | - | - | - | - |
| Net receivables | 167.51M | 242.88M | 388.35M | 659.96M | 498.95M |
| Long term debt | - | - | - | 148.74M | 176.37M |
| Inventory | - | - | - | 11.07M | 7.65M |
| Accounts payable | 46.03M | 5.74M | 69.39M | 185.51M | 109.75M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -1.56000M | -1.44100M | -1.38500M | -1.38700M | -1.29300M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | 0.00400M | 0.00400M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | 165.73M | -22.73500M |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 19.08M | 37.58M | 12.66M | 34.17M | 21.96M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 155.36M | 254.25M | 264.16M | 272.17M | 224.54M |
| Capital lease obligations | 2.32M | 3.87M | 5.27M | 9.01M | 14.94M |
| Long term debt total | - | - | - | 148.74M | 176.37M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -8.71400M | -48.01100M | -43.87400M | -34.04600M |
| Change to liabilities | - | - | - | 58.96M | 83.29M |
| Total cashflows from investing activities | -8.16100M | -8.71400M | -13.77500M | -43.87400M | -34.04600M |
| Net borrowings | 0.00000M | 0.00000M | -150.67500M | -38.50100M | 127.68M |
| Total cash from financing activities | -13.00600M | -46.84900M | -221.24100M | -87.59900M | 119.09M |
| Change to operating activities | - | - | - | -12.51600M | -2.12600M |
| Net income | -94.85200M | -14.55600M | 72.63M | 188.46M | 132.00M |
| Change in cash | 27.11M | 64.54M | 13.49M | 2.57M | -0.56400M |
| Begin period cash flow | 81.63M | 17.09M | 3.60M | 1.04M | 1.60M |
| End period cash flow | 108.74M | 81.63M | 17.09M | 3.60M | 1.04M |
| Total cash from operating activities | 48.25M | 120.12M | 248.50M | 134.05M | -85.61800M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 16.79M | 18.20M | 18.35M | 12.58M | 9.85M |
| Other cashflows from investing activities | -8.16100M | - | - | -35.08800M | -34.04600M |
| Dividends paid | - | - | - | - | - |
| Change to inventory | - | - | - | - | -83.28600M |
| Change to account receivables | 56.73M | 128.33M | 251.43M | -153.22900M | -318.42000M |
| Sale purchase of stock | -6.83300M | -37.31000M | -57.65400M | -35.28500M | -0.21000M |
| Other cashflows from financing activities | -6.17300M | -9.53900M | -12.91200M | 1682.98M | 609.96M |
| Change to netincome | - | - | - | 21.98M | -227.47200M |
| Capital expenditures | 8.16M | 8.71M | 13.97M | 8.79M | 7.17M |
| Change receivables | - | - | - | -153.22900M | -318.42000M |
| Cash flows other operating | - | - | - | 5.30M | -1.19400M |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | 2.58M | -0.57000M |
| Change in working capital | 30.46M | 87.62M | 127.48M | -106.14400M | -237.26000M |
| Stock based compensation | 7.14M | 6.03M | 6.58M | 7.39M | 6.89M |
| Other non cash items | 17.79M | 24.77M | 22.16M | 26.70M | 12.82M |
| Free cash flow | 40.09M | 111.40M | 234.52M | 125.26M | -92.78800M |
Sector: Healthcare Industry: Medical Care Facilities
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CCRN Cross Country Healthcare Inc |
0.02 0.15% | 13.19 | - | 86.96 | 0.31 | 0.99 | 0.20 | 66.42 |
| HCA HCA Healthcare, Inc. |
9.93 2.63% | 386.92 | 13.19 | 13.66 | 1.13 | 293.44 | 1.77 | 8.22 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.17 1.50% | 11.47 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
-0.15 3.30% | 4.40 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
| JDHIF JD Health International Inc |
- -% | 5.85 | 57.75 | 32.68 | 0.29 | 2.11 | 0.16 | 3.90 |
Cross Country Healthcare, Inc. provides talent management services for healthcare clients in the United States. The company operates in two segments: Nurse and Allied Staffing, and Physician Staffing. The Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel nurse and allied professionals, per diem, and healthcare leaders within nursing, allied, human resources, and finance; vendor neutral and managed services programs; and education healthcare, caregiver services, and outsourcing services. This segment offers staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term assignments, as well as workforce solutions, including MSP, VMS, RPO, project management, and other outsourcing and consultative services. It also provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. The company serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, correctional facilities, PACE programs, physician practice groups, and other healthcare providers. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments. This segment serves various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.
5201 Congress Avenue, Boca Raton, FL, United States, 33487
| Name | Title | Year Born |
|---|---|---|
| Mr. Kevin Cronin Clark | Co-Founder & Non-Exec. Chairman | 1961 |
| Mr. John A. Martins | Pres, CEO & Director | 1968 |
| Mr. William J. Burns CPA, MBA | Exec. VP, CFO & Principal Accounting Officer | 1970 |
| Ms. Susan E. Ball M.B.A., R.N., J.D., MBA, RN | Chief Admin. Officer, Exec. VP, Gen. Counsel & Sec. | 1964 |
| Mr. James V. Redd III | Sr. VP & Chief Accounting Officer | 1970 |
| Mr. Phillip Lyn Noe | Chief Information Officer | 1971 |
| Mr. Joshua David Vogel | VP of Investor Relations | NA |
| Karen Varga-Sinka | Director of Corp. Communications | NA |
| Mr. Gerald Purgay | Chief Marketing Officer | 1961 |
| Mr. Colin Patrick McDonald M.S. | Chief HR Officer | 1968 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...